Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation
- PMID: 14616983
- DOI: 10.1046/j.1365-2141.2003.04675.x
Short progression-free survival in myeloma patients receiving rituximab as maintenance therapy after autologous transplantation
Comment on
-
Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma.Br J Haematol. 2003 Aug;122(4):690-1. doi: 10.1046/j.1365-2141.2003.04478.x. Br J Haematol. 2003. PMID: 12899729 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
